High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$17.0M
$16,951,259
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-04 | $702,114x2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-03 | $1,380,149Largex2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-02 | $1,393,894Largex3 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-05 | $786,366x2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-04 | $1,544,820Largex2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-03 | $1,522,317Largex3 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-12-01 | $1,141,925Largex4 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $1,410,990Largex3 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-11 | $1,382,600Largex3 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-10 | $1,374,339Largex2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-03 | $1,380,638Largex4 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-02 | $1,424,083Largex5 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-01 | $1,507,024Largex2 | S | Form 4 |